Millennium Management
RVMD icon

Millennium Management’s Revolution Medicines RVMD Stock Holding History

Millennium Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.7M Sell
377,332
-422,786
-53% -$42.7M 0.02% 1069
2025
Q4 		$63.7M Buy
800,118
+371,809
+87% +$24.4M 0.03% 647
2025
Q3 		$20M Sell
428,309
-952,532
-69% -$37.3M 0.01% 1665
2025
Q2 		$50.8M Buy
1,380,841
+1,224,488
+783% +$47M 0.02% 808
2025
Q1 		$5.53M Buy
+156,353
New +$6.35M ﹤0.01% 2754
2024
Q2 		– Sell
-7,661
Closed -$286K – 6446
2024
Q1 		$247K Buy
+7,661
New +$227K ﹤0.01% 5257
2023
Q4 		– Sell
-247,816
Closed -$5.95M – 6469
2023
Q3 		$6.86M Sell
247,816
-126,274
-34% -$3.75M ﹤0.01% 2413
2023
Q2 		$10M Sell
374,090
-178,961
-32% -$4.39M ﹤0.01% 2024
2023
Q1 		$12M Buy
553,051
+435,447
+370% +$10.7M 0.01% 1782
2022
Q4 		$2.8M Sell
117,604
-392,921
-77% -$8.35M ﹤0.01% 3275
2022
Q3 		$10.1M Buy
510,525
+255,082
+100% +$5.61M 0.01% 2125
2022
Q2 		$4.98M Buy
255,443
+231,670
+975% +$4.51M ﹤0.01% 2816
2022
Q1 		$606K Sell
23,773
-13,376
-36% -$291K ﹤0.01% 4970
2021
Q4 		$935K Sell
37,149
-149,822
-80% -$4.22M ﹤0.01% 4469
2021
Q3 		$5.14M Buy
186,971
+145,151
+347% +$4.22M ﹤0.01% 2827
2021
Q2 		$1.33M Buy
41,820
+23,525
+129% +$821K ﹤0.01% 4400
2021
Q1 		$839K Sell
18,295
-168,134
-90% -$7.54M ﹤0.01% 4381
2020
Q4 		$7.38M Buy
+186,429
New +$7.37M 0.01% 2080
2020
Q3 		– Sell
-8,827
Closed -$279K – 4766
2020
Q2 		$279K Sell
8,827
-101,462
-92% -$3.19M ﹤0.01% 3699
2020
Q1 		$2.42M Buy
+110,289
New +$3.05M 0.01% 1875

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management's RVMD Position: Q1 2026 in Review

Millennium Management reduced its Revolution Medicines (RVMD) stake by 53% in Q1 2026, selling an estimated $42.7M and leaving 377,332 shares worth $36.7M. The position accounts for 0.02% of the portfolio, ranked #1069.

Millennium Management first reported a position in RVMD in Q1 2020 and has held it in 20 quarters since. The position peaked at $63.7M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Millennium Management held 377,332 shares of Revolution Medicines worth $36.7M as of Q1 2026.
  • Millennium Management sold 422,786 Revolution Medicines shares in Q1 2026, an estimated $42.7M.
  • Revolution Medicines made up 0.02% of Millennium Management's portfolio in Q1 2026, its #1069 holding.
  • Millennium Management first reported a position in Revolution Medicines in Q1 2020 and has held it in 20 quarters since.
  • Millennium Management's Revolution Medicines position peaked at $63.7M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.